Valuation: MediWound Ltd.

Capitalization 186M 180M 170M 150M 266M 16.16B 296M 2.02B 751M 6.71B 698M 684M 28.36B P/E ratio 2024 *
-5.2x
P/E ratio 2025 * -7.72x
Enterprise value 186M 180M 170M 150M 266M 16.16B 296M 2.02B 751M 6.71B 698M 684M 28.36B EV / Sales 2024 *
9.23x
EV / Sales 2025 * 7.35x
Free-Float
80.25%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: MediWound Ltd.

1 day-1.60%
1 week-11.49%
Current month-11.85%
1 month+3.23%
3 months-0.75%
6 months-4.38%
Current year-3.03%
More quotes
1 week
16.90
Extreme 16.9
20.30
1 month
16.90
Extreme 16.9
20.62
Current year
15.80
Extreme 15.8
20.62
1 year
12.15
Extreme 12.15
24.00
3 years
7.10
Extreme 7.1
24.00
5 years
7.10
Extreme 7.1
43.54
10 years
7.10
Extreme 7.1
73.29
More quotes
Director TitleAgeSince
Chief Executive Officer 50 2022-06-29
Director of Finance/CFO 53 2023-05-13
Chief Tech/Sci/R&D Officer - 2023-08-31
Manager TitleAgeSince
Director/Board Member 52 2022-06-29
Director/Board Member 71 2017-05-17
Chairman 68 2017-10-24
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.60%-11.49%+45.04%+6.74% 186M
-0.26%-5.20%-11.70%+5.22% 78.34B
+3.89%+17.40%+44.05%+55.70% 57.55B
+0.37%+1.71%+101.16%+123.81% 37.18B
-2.21%-2.18%-42.16%-35.04% 20.31B
-3.57%+1.07%+392.19%+839.13% 13.87B
+0.35%+0.52%+75.29%+140.63% 13.55B
-2.88%-10.51%+15.04%-0.64% 12.84B
+0.08%+1.08%-28.16%-30.10% 12.11B
-1.84%-2.83%+5.42%-36.66% 11.45B
Average -0.77%-1.61%+59.62%+106.88% 25.74B
Weighted average by Cap. +0.27%-0.16%+42.38%+78.72%
See all sector performances

Financials

2024 *2025 *
Net sales 20.18M 19.5M 18.41M 16.24M 28.87M 1.75B 32.05M 219M 81.34M 727M 75.61M 74.12M 3.07B 25.35M 24.5M 23.13M 20.41M 36.27M 2.2B 40.26M 275M 102M 914M 94.99M 93.11M 3.86B
Net income -32.6M -31.51M -29.75M -26.25M -46.64M -2.83B -51.78M -354M -131M -1.18B -122M -120M -4.96B -22.96M -22.19M -20.95M -18.48M -32.84M -1.99B -36.46M -249M -92.53M -828M -86.02M -84.32M -3.5B
Net Debt - -
More financial data * Estimated data
Logo MediWound Ltd.
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Employees
-
More about the company
Date Price Change Volume
25-02-11 17.26 $ -1.60% 42,598
25-02-10 17.54 $ -3.25% 90,148
25-02-07 18.13 $ -7.03% 65,203
25-02-06 19.50 $ -4.08% 36,433
25-02-05 20.33 $ +4.26% 121,106

Delayed Quote Nasdaq, February 11, 2025 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
17.26USD
Average target price
29.00USD
Spread / Average Target
+68.02%
Consensus

Quarterly revenue - Rate of surprise